France· FR:62736105

CATIOLANZE 50 microgrammes/mL, collyre en émulsion

A latanoprost product containing latanoprost, registered in France by SANTEN OY, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC S01EE01

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about latanoprostAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Latanoprost is registered in 18 of 19 countries.

Countries holding a registration under ATC S01EE01 (latanoprost), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
10 of them publish a price we can compare per daily dose

Search latanoprost products by name

Latanoprost · ATC S01EE01

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: LATANOPROST
Manufacturer: SANTEN OY
Country: France (FR)
ATC code: S01EE01
ATC class: Latanoprost
Defined daily dose: 0.1 ml, AT
Reimbursed: Yes
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

cip13
3400930294185
30 rÃ©cipients unidoses de 0,3 mL polyÃ©thylÃ¨ne basse densitÃ© (PEBD) en sachets de (6 x 5 rÃ©cipients unidoses) aluminium polyÃ©thylÃ¨ne
EUR 7.03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

173 interactions on record for latanoprost.

Graded by severity as the source publishes them — 173 info. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check latanoprost against other medicines How interaction checks work

Latanoprost · interactions on record

173 records

173 info

Most severe, free to view

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Latanoprost in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All latanoprost products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Akistan, Latacris
Belgium · Latanea, Latanoprost Eg
Bulgaria · Akistan, Ксалатан
Cyprus · Gisolom, Latanoprost Demo
Czechia · Akistan, Latanoprost Olikla
Germany · Akistan, Latanelb
Denmark · Latanoprost Genetic, Latanoprost Rivopharm
Estonia · Glaumax, Latanoprost Actavis
Spain · Latanest, Latanoprost Aurovitas
Finland · Latanoprost Sandoz, Latanoprost Stada
United Kingdom (Northern Ireland) · Latanoprost, Latanoprost Accord
Greece · Latandrops, Lataneau
Croatia · Lapovis, Latanox
Hungary · Akistan, Laprosep
Ireland · Latanoprost Genetic, Loravis
Iceland · Catiolanze, Latanoprost Actavis
Italy · Droplatan, Galaxia
Liechtenstein · Catiolanze
Lithuania · Latanoprost Actavis, Latanoprost Elvim
Luxembourg · Latanea, Latanoprost Eg
Latvia · Latanoprost Actavis, Latanoprost Elvim
Malta · Latanoprost Genetic, Lunaris
Netherlands · Latanea, Latanmono Conserveermiddelvrij
Norway · Catiolanze, Ditiamgo
Poland · Akistan, Latanoprost Genoptim
Portugal · Enicil, Enicilfree
Romania · Akistan, Glautan
Sweden · Latanoprost Actavis, Latanoprost Genetic
Slovenia · Akistan, Latanoprost Genetic
Slovakia · Akistan, Latanoprost Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a98e9e28-c823-4056-9066-953f17301ff1
GET /v1/drugs/a98e9e28-c823-4056-9066-953f17301ff1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62736105",
  "date_amm": "2023-11-15",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/23/1763",
  "substance": "LATANOPROST",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "collyre en émulsion",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about latanoprost.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console